BioHarvest Sciences Inc. operates as a biotechnology company. The company operates through Nutraceuticals and Pharmaceuticals segments. It develops botanical synthesis platform technology to grow the ingredients in any plant enzymes or cells. The company is leveraging its botanical synthesis technology to develop science-based and clinically proven therapeutic solutions in nutraceuticals and pharmaceuticals verticals. It also operates as a contract development and manufacturing operation services. In addition, the company offers wellness products. Further, it offers VINIA, a red grape cell dietary supplement containing the matrix of polyphenols contained in red grapes. The company operates in Israel and the United States. BioHarvest Sciences Inc. is based in Vancouver, Canada.
Frequently asked questions
What sector does BioHarvest Sciences Inc. (CNVCD) operate in?
BioHarvest Sciences Inc. belongs to the Other sector and operates in the Packaged Foods industry.
What is BioHarvest Sciences Inc. (CNVCD) current stock price?
As of the latest data, BioHarvest Sciences Inc. stock price is $2.70, with a previous close of $2.70.
Does BioHarvest Sciences Inc. (CNVCD) pay dividends?
No. BioHarvest Sciences Inc. does not pay a dividend.
What is BioHarvest Sciences Inc. (CNVCD) beta (volatility) score?
BioHarvest Sciences Inc. has a beta of -4.089, indicating lower volatility than the overall market.
